AFRICAN-AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK) COHORT STUDY

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 AASK(非裔美国人肾脏疾病和高血压研究)的主要目标是前瞻性地确定接受推荐抗高血压治疗的患有高血压的非裔美国人的肾功能进程和肾脏进展的危险因素。第二个目标是确定心血管疾病的发生并评估其危险因素。归根结底，来自AASK队列研究的数据应该会加强我们对决定肾脏疾病进展的风险因素和过程的理解。这样的结果可能会导致延迟或预防ESRD的新战略。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of the AASK (African-American Study of Kidney Disease and Hypertension) is to determine prospectively the course of kidney function and risk factors for kidney progression in African-Americans with hypertensive kidney who receive recommended antihypertensive therapy. A second objective is to determine the occurrence of cardiovascular disease and assess its risk factors. Ultimately data from the AASK Cohort Study should enhance our understanding of the risk factors and processes that determine the progression of kidney disease. Such results might lead to new strategies that delay or prevent ESRD.